Treatment of ligneous conjunctivitis.
D001284:Atrophy; D002648:Child; D002807:Chondroitin / Q000378:metabolism; D002918:Chymotrypsin / Q000627:therapeutic use*; D003231:Conjunctivitis / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D003318:Corneal Opacity / Q000150:complications; D005143:Eyelids / Q000473:pathology*; D005260:Female; D006025:Glycosaminoglycans / Q000378:metabolism; D006801:Humans; D006820:Hyaluronic Acid / Q000378:metabolism; D006821:Hyaluronoglucosaminidase / Q000627:therapeutic use*; D008875:Middle Aged; D009092:Mucous Membrane / Q000473:pathology; D009093:Mucus
D006025:Glycosaminoglycans; D006820:Hyaluronic Acid; D002807:Chondroitin; D006821:Hyaluronoglucosaminidase; D002918:Chymotrypsin